288 related articles for article (PubMed ID: 20650546)
1. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
Berger J; Diab-Elschahawi M; Blacky A; Pernicka E; Spertini V; Assadian O; Koller W; Aichberger KJ
Am J Infect Control; 2010 Dec; 38(10):839-45. PubMed ID: 20650546
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.
Wu UI; Yang CS; Chen WC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):310-6. PubMed ID: 20688291
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
6. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
[TBL] [Abstract][Full Text] [Related]
9. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
[No Abstract] [Full Text] [Related]
10. Low occurrence of antibiotic resistance in Escherichia coli and staphylococci isolated from blood cultures in two Norwegian hospitals in 1991-92 and 1995-96.
Leegaard TM; Vik E; Caugant DA; Frøholm LO; Høiby EA
APMIS; 1999 Dec; 107(12):1060-8. PubMed ID: 10660135
[TBL] [Abstract][Full Text] [Related]
11. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
[TBL] [Abstract][Full Text] [Related]
12. [Excess mortality and prolongation of stay due to bloodstream infections caused by multiresistant pathogens in Germany].
Gastmeier P; Schwab F; Meyer E; Geffers C
Dtsch Med Wochenschr; 2012 Aug; 137(34-35):1689-92. PubMed ID: 22893048
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort.
Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Kim SW; Chang HH; Kim YS; Jung SI; Son JS; Hsueh PR; So TM; Lalitha MK; Yang Y; Huang SG; Wang H; Lu Q; Carlos CC; Perera JA; Chiu CH; Liu JW; Chongthaleong A; Thamlikitkul V; Van Pham H;
J Infect; 2010 Oct; 61(4):299-306. PubMed ID: 20670652
[TBL] [Abstract][Full Text] [Related]
14. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.
Khatib R; Johnson LB; Fakih MG; Riederer K; Khosrovaneh A; Shamse Tabriz M; Sharma M; Saeed S
Scand J Infect Dis; 2006; 38(1):7-14. PubMed ID: 16338832
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
[TBL] [Abstract][Full Text] [Related]
16. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.
Khatib R; Riederer K; Saeed S; Johnson LB; Fakih MG; Sharma M; Tabriz MS; Khosrovaneh A
Clin Infect Dis; 2005 Sep; 41(5):594-8. PubMed ID: 16080079
[TBL] [Abstract][Full Text] [Related]
17. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study.
Chang HJ; Hsu PC; Yang CC; Kuo AJ; Chia JH; Wu TL; Lee MH
J Microbiol Immunol Infect; 2011 Apr; 44(2):125-30. PubMed ID: 21439515
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study.
Walker TM; Bowler IC; Bejon P
J Infect; 2009 Jun; 58(6):411-6. PubMed ID: 19394703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
